Mirae Raises $5.4 Million to Expand AI Platform for Chronic Disease Care
Top Picks
Stay Ahead of the Market
Get the latest startup funding, hiring trends and global opportunities delivered to your inbox every week.
Mirae Secures $5.4 Million in Funding
London-based Mirae has raised $5.4 million in funding to expand its AI-powered continuous care platform for autoimmune diseases and other complex chronic conditions.
The round was led by Oxford Science Enterprises.
Led by CEO Anuj Patel, Mirae develops a conversational AI platform that helps clinicians monitor patients between appointments by transforming patient-reported experiences into structured clinical insights.
Using AI to Support Continuous Care
Built on research from the University of Oxford's Computational Health Informatics Lab, Mirae's platform captures patient-reported information between clinical visits and converts it into a continuous view of disease progression.
The conversational AI system combines symptom trajectories, treatment history, laboratory data, and peer-reviewed clinical evidence to provide healthcare professionals with actionable insights during routine care.
By integrating longitudinal patient data into existing clinical workflows, the platform aims to support more informed treatment decisions for individuals living with chronic conditions.
Supporting Growth and Research
The newly raised funding will be used to expand Mirae's operations and accelerate its research and development efforts.
The investment supports the company's mission to improve long-term disease management through AI-powered continuous monitoring and clinical decision support.
